Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

Finasteride, when taken daily, lowers dihydrotestosterone levels but doesn't noticeably affect adrenal steroid production, except by blocking the 5 alpha-reductase enzyme.

D-004 may be a natural alternative to finasteride for treating enlarged prostate and male baldness.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Topical finasteride doesn't reduce DHT levels, hinting at an endocrine role in hair loss.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Incidental prostate cancer was found in 4.89% of patients undergoing surgery for benign prostatic hyperplasia.

Taking both finasteride and dutasteride for prostate issues may raise the risk of heart problems.

Finasteride helps treat hair loss and prostate enlargement by blocking a specific enzyme.

Finasteride and dutasteride reduce prostate cancer risk, but finasteride may increase higher-grade cancer risk.

Dutasteride improved hair density and thickness in men not helped by finasteride, with minimal side effects.

The enzyme that changes testosterone to a stronger form is mostly found in the part of the hair follicle called the dermal papilla.

DHT may increase the risk of heart disease and death in elderly men.

Finasteride reduces DHT to treat prostate issues and hair loss.

Reducing 5α-reductase activity helps endometrial cells differentiate, aiding pregnancy.

Dutasteride is more effective than finasteride for treating BPH without extra safety risks.

Dihydrotestosterone changes some hormone-related gene expressions in rat pituitary glands but doesn't affect the estrous cycle.

Combining D-004 and finasteride is more effective at reducing prostate enlargement than using either alone.

Arachis hypogaea L. root extract reduces prostate enlargement and inflammation in mice.

Certain adrenal hormones can strongly stimulate oil gland growth in hamster skin, similar to male hormones.

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

Antiandrogens and finasteride may help treat excess hair and hair loss in women.

Finasteride significantly reduces PSA levels in men, and doctors should adjust PSA readings for those taking the drug.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Lack of sleep in mice leads to prostatitis by reducing certain hormones and activating an inflammatory pathway, which can be temporarily fixed with normal sleep.

Dutasteride use can lead to a stable decline in sexual function that is not affected by age or prostate size.

Finasteride reduces sperm count and affects male reproductive function, while Epristeride does not.

Finasteride safely lowers DHT levels without affecting testosterone.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

Finasteride may reduce prostate tumor cell invasion and spread.